nivolumab

Bristol immunotherapy shows promise in lung cancer trial
Bristol immunotherapy shows promise in lung cancer trial
Yahoo/AP
Bristol-Myers Squibb
non-small cell lung cancer
nivolumab
Flag link:
Most popular news headlines for Monday, August 4 2014
Most popular news headlines for Monday, August 4 2014
CP Wire
ebola virus
TKM-EBOLA
Bristol-Myers Squibb
GSK
Sanofi
Advair
nivolumab
Flag link:
FirstWord Lists: Pharma's biggest pipeline drugs
FirstWord Lists: Pharma's biggest pipeline drugs
First Word Pharma
pipelines
nivolumab
Pembrolizumab
evolocumab
palbociclib
cancer
breast cancer
Pfizer
Bristol-Myers Squibb
Merck
Amgen
Flag link:
Bristol-Myers Squibb May Be Fast-Tracking Its Promising Cancer Drug
Bristol-Myers Squibb May Be Fast-Tracking Its Promising Cancer Drug
Seeking Alpha
Bristol-Myers Squibb
nivolumab
fast track
immuno-oncology
Flag link:
Pharma’s Huge Bet on Immunotherapies
Pharma’s Huge Bet on Immunotherapies
Motley Fool
immunotherapy
anti-PD-1 immunotherapy
anti-PD-L1
MK-3475
Merck
nivolumab
Roche
Bristol-Myers Squibb
Flag link:
Bristol-Myers says Phase 3 study of nivolumab versus dacarbazine stopped early
Bristol-Myers says Phase 3 study of nivolumab versus dacarbazine stopped early
Yahoo/Fly on the Wall
nivolumab
Bristol-Myers Squibb
dacarbazine
melanoma
Flag link:
Bristol Shares Sag On Cancer Drug Worries
Bristol Shares Sag On Cancer Drug Worries
Forbes
Bristol-Myers Squibb
Yervoy
nivolumab
cancer
Flag link:
Bristol Defends Data; Roche Shines In Cancer Showdown
Bristol Defends Data; Roche Shines In Cancer Showdown
Investors.com
Roche
Bristol-Myers Squibb
nivolumab
Yervoy
melanoma
MPDL3280A
bladder cancer
ASCO
Flag link:
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
U.S. to test Bristol-Myers immunotherapy drugs on newly diagnosed brain tumors
Yahoo/Reuters
Yervoy
brain cancer
immunotherapy
Bristol-Myers Squibb
ASCO
nivolumab
Flag link:
Bristol-Myers, Incyte enter collaboration agreement for nivolumab, INCB24360
Bristol-Myers, Incyte enter collaboration agreement for nivolumab, INCB24360
The Fly on the Wall
Bristol-Myers Squibb
Incyte
nivolumab
melanoma
non-small cell lung cancer
colorectal cancer
ovarian cancer
INCB24360
Flag link:
Bristol-Myers: Nivolumab Holds Good Potential
Bristol-Myers: Nivolumab Holds Good Potential
Seeking Alpha
nivolumab
Bristol-Myers Squibb
Flag link:
6 Drugs That Could Move the Pharma Market
6 Drugs That Could Move the Pharma Market
Wall St Cheat Sheet
Gilead Sciences
Teva Pharmaceuticals
Copaxone
Idelalisib
Bristol-Myers Squibb
nivolumab
Cyramza
Eli Lilly
Pfizer
palbociclib
Sovaldi
Flag link:
Bristol-Myers racing to the FDA with immunotherapy star nivolumab
Bristol-Myers racing to the FDA with immunotherapy star nivolumab
Fierce Biotech
FDA
immunotherapy
nivolumab
Bristol-Myers Squibb
Flag link:
Durable melanoma remission seen with Bristol immunotherapy drug
Durable melanoma remission seen with Bristol immunotherapy drug
Yahoo/Reuters
Bristol-Myers Squibb
nivolumab
melanoma
metastatic melanoma
Flag link:
Bristol-Myers - Nivolumab's Delays Warrant Friday's Sell-Off
Bristol-Myers - Nivolumab's Delays Warrant Friday's Sell-Off
Seeking Alpha
Bristol-Myers Squibb
nivolumab
AstraZeneca
Flag link:
Pace of Bristol-Myers' cancer trial spooks investors
Pace of Bristol-Myers' cancer trial spooks investors
Yahoo/Reuters
Bristol-Myers Squibb
nivolumab
lung cancer
Flag link:
Bristol-Myers' New Nivolumab Trial Sparks Worries
Bristol-Myers' New Nivolumab Trial Sparks Worries
Investors.com
Bristol-Myers Squibb
nivolumab
clinical trials
non-small cell lung cancer
Flag link:
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Bristol-Myers Squibb Vs. Roche In The Brain Cancer Race
Seeking Alpha
Bristol-Myers Squibb
Roche
brain cancer
CytRx
Celldex Therapeutics
ImmunoCellular Therapeutics
Northwest Biotherapeutics
glioblastoma multiforme
nivolumab
Yervoy
Flag link:
Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade
Bristol-Myers Squibb Gains 6% on Promising Cancer Treatment, Upgrade
Barron's
Bristol-Myers Squibb
nivolumab
lung cancer
Flag link:
Cancer immunotherapies turn a corner in race to megablockbuster market
Cancer immunotherapies turn a corner in race to megablockbuster market
Fierce Biotech
cancer immunotherapy
Merck
MK-3475
nivolumab
Bristol-Myers Squibb
Roche
MPDL3280A
PDL-1
Flag link:

Pages